Open | $15.770 |
Close | $15.560 |
Volume / Avg. | 1.059M / 1.304M |
Day Range | 15.530 - 16.210 |
52 Wk Range | 5.710 - 16.510 |
Market Cap | $1.183B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 64 |
Short Interest | 12.86% |
Days to Cover | 7.8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Liquidia (NASDAQ: LQDA) through any online brokerage.
Other companies in Liquidia’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and Tarsus Pharmaceuticals (NASDAQ:TARS).
The latest price target for Liquidia (NASDAQ: LQDA) was reported by HC Wainwright & Co. on Thursday, March 14, 2024. The analyst firm set a price target for 32.00 expecting LQDA to rise to within 12 months (a possible 105.66% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Liquidia (NASDAQ: LQDA) is $15.56 last updated March 18, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Liquidia.
Liquidia’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Liquidia.
Liquidia is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.